What is B. Riley’s Estimate for OVID Q2 Earnings?
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – B. Riley issued their Q2 2025 earnings per share (EPS) estimates for shares of Ovid Therapeutics in a report issued on Thursday, May 15th. B. Riley analyst K. Patel forecasts that the company will post earnings of ($0.16) per share for the quarter. The consensus estimate for […]
